Back
Apellis Pharmaceuticals, Inc. Vs. Enova International, Inc. Industry Stock Comparison
Buy
57
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$24.97
Seasonality Move:
7.92%
Buy
88
ENVA
Enova International, Inc.
Last Price:
$157.90
Seasonality Move:
12.67%
Buy
57
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.97. The Score for APLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
88
Enova International, Inc. (ENVA)
is a Buy
Is Enova International, Inc. a Buy, Sell or Hold?
-
The current Enova International, Inc. [ENVA] share price is $157.92. The Score for ENVA is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
-
ENVA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $24.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
ENVA Stock Price Chart
What is Enova International, Inc.'s stock price today?
-
The Enova International, Inc. share price today is $157.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 67.36 | Buy |
| Chaikin Money Flow: | -208746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.29 - 22.81) | Buy |
| Bollinger Bands (100): | (20.75 - 26.93) | Buy |
ENVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.16 | Buy |
| Relative Strength Index (14 RSI): | 83.89 | Buy |
| Chaikin Money Flow: | 482423 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.94 - 138.04) | Buy |
| Bollinger Bands (100): | (107.91 - 128.31) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.12 | Buy |
| 20-day SMA: | 21.44 | Buy |
| 50-day SMA: | 23.06 | Buy |
| 200-day SMA: | 21.92 | Buy |
| 8-day EMA: | 23.44 | Buy |
| 20-day EMA: | 22.39 | Buy |
| 50-day EMA: | 22.63 | Buy |
| 200-day EMA: | 24.24 | Buy |
ENVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.78 | Buy |
| 20-day SMA: | 130.92 | Buy |
| 50-day SMA: | 122.16 | Buy |
| 200-day SMA: | 108.27 | Buy |
| 8-day EMA: | 140.61 | Buy |
| 20-day EMA: | 133.44 | Buy |
| 50-day EMA: | 125.94 | Buy |
| 200-day EMA: | 111.37 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Enova International, Inc. Earnings Growth & ENVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.92 per share, and an increase next year of $1.81 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Enova International, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||